|
CXCR4-Targeting Molecules for Tumor Metastasis and PET Imaging
Application
Positron emission tomography (PET) imaging agents with high specificity for metastatic cancer.
Key Benefits
18F-labeled CXCR4 (partial) antagonist without stem cell mobilizing property is safe to be given to patient multiple times.
Identifies tumor location non-invasively and provides an indication of tumor’s metastatic potential.
Market...
Published: 4/23/2024
Contributor(s): Hyunsuk Shim, Mark Goodman, Dinesh Shetty, Yoon Hyeun Oum
|
|
Novel Piperidine-Amide Derivatives as CXCR4 Modulators
Application
A new class of CXCR4 modulators for metastasis and inflammation.
Key Benefits
Selective for only one allosteric site on CXCR4.
Lower adverse effects.
Market Summary
Activation of the CXCR4 receptor triggers multiple signaling pathways that orchestrate cell migration, hematopoiesis and cell homing, and retention in the bone...
Published: 11/27/2023
Contributor(s): Hyunsuk Shim, Yoon Hyeun Oum
|
|
HDAC Inhibitors for Managing Vascular Conditions and Diabetic Peripheral Neuropathies
Application
Treatment of diabetic neuropathy using epigenetic modulators, histone deacetylase inhibitors (HDACis), to ameliorate or prevent vascular conditions and neuropathic pains by nerve damages.
Key Benefits
Reverses or protects against diabetes-induced nerve damages by direct injection of HDACi.
Relatively low regulatory risk because many...
Published: 4/23/2024
Contributor(s): Young-Sup Yoon, Ji Woong (Jay) Han, Hyunsuk Shim
|
|
Chimeric Molecule for the Treatment of Depression
Application
Small molecules for treating depression and/or depression associated with cancer/chemotherapy.
Key Benefits
Potentially a dual mechanism compound – working via monoamine reuptake inhibition and HDAC inhibition (epigenetic modification).
Quicker acting compound compared to current therapies in the market. Works better than the...
Published: 4/23/2024
Contributor(s): Hyunsuk Shim, Huw Davies, Hyun Min Park, Yoon Hyeun Oum
|
|
Web based Software for Whole-Brain Spectroscopic MRI in Patients with Neuropathologies (BrICS)
Application
Web-based application for visualizing and analyzing spectroscopic MRI data (sMRI, MRSI) in diagnosing, treatment planning, and monitoring of neuropathologies such as tumor.
Key Benefits
Enables the analysis of multiple diagnostic images simultaneously.
Generates a heat map of metabolite (e.g., CHO/NAA) levels to better diagnose malignancies.
Incorporates...
Published: 4/10/2024
Contributor(s): Hyunsuk Shim, Saumya Gurbani, Lee Cooper, Andrew Maudsley, Sulaiman Sheriff
|
|
Derivatives as CXCR4 Modulators for the Treatment of Inflammation and Metastasis
Application
Amide derivatives as chemokine receptor type 4 (CXCR4) modulators for the treatment of inflammation or prevention of cancer cell metastasis.
Key Benefits
Excellent binding affinity, compared to currently available compounds targeting CXCR4 receptor.
Stability in plasma compared to protein/peptide agonists of CXCR4, these amide derivatives...
Published: 4/23/2024
Contributor(s): Hyunsuk Shim, Renren Bai, Qi Shi
|
|
CXCR4 Modulator for Preventing Cancer Metastasis
Application
Amine derivatives as chemokine receptor type 4 (CXCR4) modulators to treat breast cancer and block tumor metastasis.
Key Benefits
New class of anti-cancer drugs targeting CXCR4 instead of COX pathway.
Partial antagonists are safer for use because they do not mobilize stem cells.
Market Summary
CXC chemokine receptor 4 (CXCR4) and...
Published: 4/23/2024
Contributor(s): Hyunsuk Shim, Renren Bai, Suazette Mooring
|